FindTrial
Sign In

Usage of topical lignocaine to decrease the gag reflex while sampling for Covid-19: Does it affect the yield of specimen?

Usage of topical lignocaine to decrease the gag reflex while sampling for Covid-19: Does it affect the yield of specimen?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/024983
Enrollment
30
Registered
2020-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Topical Lignocaine: Topical lignocaine lozenges to be used before collecting nasal and throat swabs for Covid-19

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: RT-PCR proven COVID19 positive cases

Exclusion criteria

Exclusion criteria: Pregnancy, minors, refusal to participate, patient on ventilatory support

Design outcomes

Primary

MeasureTime frame
The sensitivity of nasal and throat swabs for RT-PCR of Covid-19 after topical lignocaine useTimepoint: none—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactAlok Thakar

All India Institute of Medical Sciences

drathakar@gmail.com9868397471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026